Skip to main content
HEALIUS LIMITED logo

HEALIUS LIMITED — Investor Relations & Filings

Ticker · HLS ISIN · AU0000033359 LEI · 529900MBZK3SLWK8SJ55 ASX Human health and social work activities
Filings indexed 2,292 across all filing types
Latest filing 2022-03-02 Major Shareholding Noti…
Country AU Australia
Listing ASX HLS

About HEALIUS LIMITED

https://www.healius.com.au

Healius Limited is a leading healthcare service provider specializing in pathology and diagnostic imaging services. The company operates an extensive network of pathology laboratories and collection centers, providing diagnostic testing across various medical disciplines including biochemistry, hematology, and microbiology. Its diagnostic imaging division offers a comprehensive range of services such as X-rays, ultrasounds, CT scans, and MRIs through a network of community-based and hospital-integrated clinics. Healius focuses on delivering high-quality diagnostic insights to healthcare professionals and patients, leveraging advanced technology and a large-scale infrastructure to support clinical decision-making and patient care outcomes.

Recent filings

Filing Released Lang Actions
Becoming a substantial holder 3 pages 95.7KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 filed under the Corporations Act 2001 Section 671B, titled 'Notice of initial substantial holder.' It details the substantial shareholding of Vinva Investment Management Limited in Healius Limited, including voting power, relevant interests, registered holders, and consideration paid. This form is a regulatory notification of a substantial shareholding, which corresponds to a Major Shareholding Notification filing. The document is about notifying changes in significant share ownership levels, not a financial report or other types of filings.
2022-03-02 English
Update - Dividend/Distribution - HLS 4 pages 25.8KB
Notice of Dividend Amount Classification · 100% confidence The document is a notification regarding a dividend distribution update, specifically bringing forward the payment date of the 2022 Interim Dividend. It includes details such as record date, ex-date, payment date, dividend amount, and franked status. The content is focused on dividend announcement details rather than a full financial report or earnings release. Therefore, it fits the category of Notice of Dividend Amount (DIV). The document length and content confirm it is not merely an announcement of a report but a substantive dividend notification.
2022-03-01 English
Notification of cessation of securities - HLS 4 pages 24.6KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Notification of cessation of +securities' and details the cancellation of securities due to an on-market buy-back. It includes specific information about the number of securities ceased, the reason for cessation, dates, and consideration paid. The document is a formal announcement to the ASX about changes in the company's issued capital due to share buy-back activity. It does not contain financial statements, management discussion, or detailed financial results. It is not a report but an announcement of a capital change event. Therefore, it fits the category of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares.
2022-02-24 English
Application for quotation of securities - HLS 7 pages 30.4KB
Regulatory Filings Classification · 95% confidence The document is an application for quotation of securities issued under an employee incentive scheme by Healius Limited. It details the number and type of securities to be quoted, issue dates, and related information. The content is regulatory in nature, related to securities issuance and listing on the ASX, but it is not a financial report, earnings release, or management discussion. It is not a report publication announcement since it contains substantive details about the securities issuance. The document fits best under the category of Regulatory Filings (RNS) as it is a formal regulatory announcement about securities quotation and issuance under ASX rules.
2022-02-23 English
Appendix 3Y Change of Directors Interest Notice 2 pages 606.7KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details the change in securities held by a director, including the number of shares before and after the change, the nature of the change, and the date of the change. There is no financial performance data, earnings information, or report content. The document is a formal notification of a director's personal share transactions, which fits the definition of Director's Dealing (DIRS). The document length is 3409 characters, consistent with a notice rather than a full report. Therefore, the correct classification is DIRS with high confidence.
2022-02-23 English
Appendix 3Y Change of Directors Interest Notice 2 pages 595.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including number of shares held before and after the change, nature of the change, and consideration value. The document is a formal notification of a director's personal share transactions, which aligns with the definition of Director's Dealing filings. The document length is 3686 characters, which is consistent with a detailed notice rather than a brief announcement. There is no indication that this is a full financial report or other type of filing. Therefore, the correct classification is Director's Dealing (DIRS).
2022-02-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.